InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| ISD | Protocol for nuclear export signal characterization of cGAS in mammalian cells. | 2021 | STAR Protoc. | Huang Y. et al. | DOI: 10.1016/j.xpro.2021.100649 |
| pVITRO2-MCS | Dual-Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts ... | 2021 | Hepatol Commun. | Chen K. et al. | DOI: 10.1002/hep4.1701 |
| 5'ppp-dsRNA Control | Roles of the ubiquitin ligase CUL4B and ADP-ribosyltransferase TiPARP in TCDD... | 2021 | J Biol Chem. | Paz Rijo M. et al. | DOI: 10.1016/j.jbc.2021.100886 |
| 5'ppp-dsRNA | Roles of the ubiquitin ligase CUL4B and ADP-ribosyltransferase TiPARP in TCDD... | 2021 | J Biol Chem. | Paz Rijo M. et al. | DOI: 10.1016/j.jbc.2021.100886 |
| Leptomycin B | Quantitative Nucleocytoplasmic Transport Assays in Cellular Models of Neurode... | 2020 | Bio Protoc. | Vanneste J. et al. | DOI: 10.21769/BioProtoc.3659 |
| Leptomycin B | Intron-containing RNA from the HIV-1 provirus activates type I interferon and... | 2018 | Nat Commun. | McCauley S.M. et al. | DOI: 10.1038/s41467-018-07753-2 |
| Leptomycin B | Unrestrained ESCRT-III drives micronuclear catastrophe and chromosome fragmen... | 2020 | Nat Cell Biol. | Vietri M. et al. | DOI: 10.1038/s41556-020-0537-5 |
| Leptomycin B | C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocy... | 2019 | Sci Rep. | Vanneste J. et al. | DOI: 10.1038/s41598-019-52035-6 |
| Puromycin | LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in ... | 2021 | J Hematol Oncol. | Qian X. et al. | DOI: 10.1186/s13045-021-01123-0 |
| Human ACE2 expressing A549 Cells | In vitro efficacy of artemisinin-based treatments against SARS-CoV-2. | 2021 | Sci Rep. | Zhou Y. et al. | DOI: 10.1038/s41598-021-93361-y |
| Puromycin | In vitro efficacy of artemisinin-based treatments against SARS-CoV-2. | 2021 | Sci Rep. | Zhou Y. et al. | DOI: 10.1038/s41598-021-93361-y |
| HEK-Blue™ hTLR2 | Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. | 2021 | Nat Commun. | Yang Y. et al. | DOI: 10.1038/s41467-021-24536-4 |
| HEK-Blue™ Selection | Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. | 2021 | Nat Commun. | Yang Y. et al. | DOI: 10.1038/s41467-021-24536-4 |
| ORN06/LyoVec™ | Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. | 2021 | Nat Commun. | Yang Y. et al. | DOI: 10.1038/s41467-021-24536-4 |
| R848 (Resiquimod) | Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. | 2021 | Nat Commun. | Yang Y. et al. | DOI: 10.1038/s41467-021-24536-4 |
| Zeocin™ | Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. | 2021 | Nat Commun. | Yang Y. et al. | DOI: 10.1038/s41467-021-24536-4 |
| HEK-Blue™ hTLR4 | Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. | 2021 | Nat Commun. | Yang Y. et al. | DOI: 10.1038/s41467-021-24536-4 |
| HEK-Blue™ Null1 Cells | Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. | 2021 | Nat Commun. | Yang Y. et al. | DOI: 10.1038/s41467-021-24536-4 |
| Blasticidin | Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. | 2021 | Nat Commun. | Yang Y. et al. | DOI: 10.1038/s41467-021-24536-4 |
| QUANTI-Blue™ | Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. | 2021 | Nat Commun. | Yang Y. et al. | DOI: 10.1038/s41467-021-24536-4 |